Gastroenterology & Hepatology

Therapeutic Advances in Inflammatory Bowel Disease (IBD)

This track focuses on recent advancements in the treatment of IBD, including Crohn's disease and ulcerative colitis. Researchers evaluate the efficacy and safety of biologic agents, small molecule inhibitors, and immunomodulatory therapies, as well as the role of combination therapy, treat-to-target strategies, and personalized treatment approaches in optimizing disease control and long-term outcomes for patients with IBD.